05:11pm Tuesday 22 October 2019

Trial of UCI-created stem cell therapy open to U.S., Canadian patients

Brian Cummings and Aileen Anderson

Aileen Anderson and Brian Cummings (pictured) of UCI’s Sue & Bill Gross Stem Cell Research Center collaborated with StemCells Inc. to develop the treatment, in which purified human neural stem cells introduced into the spinal column grow into neural tissue cells that migrate to spinal cord injury sites. The Phase I/II trial, based at Balgrist University Hospital in Zurich, is testing both safety and preliminary efficacy in patients who are three to 12 months post-injury. Overall, 12 patients will be enrolled in the trial.

Media Contact

Share on:

MORE FROM Drugs Approvals and Trials

Health news